Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

被引：0

作者：

Buldini, Barbara ^{[1
]}

Merli, Pietro ^{[2
]}

Varotto, Elena ^{[1
,3
]}

Masetti, Riccardo ^{[4
]}

Gabelli, Maria ^{[1
]}

Zecca, Marco ^{[5
]}

Fagioli, Franca ^{[6
]}

Scarparo, Pamela ^{[1
]}

Algeri, Mattia ^{[2
]}

Biffi, Alessandra ^{[7
]}

Pigazzi, Martina ^{[8
]}

Pagliara, Daria ^{[2
]}

Locatelli, Franco ^{[9
,10
]}

机构：

[1] Univ Padua, Pediat Hematol Oncol & Stem Cell Transplant Div, Maternal & Child Hlth Dept, Padua, Italy

[2] Bambino Gesu Children Hosp, Dept Haematol Oncol & Cell & Gene Therapy, Rome, Italy

[3] Univ Padua, Padua, Italy

[4] Dept P, Pediat Oncol & Hematol Unit lalla Seragnoli, Bologna, Italy

[5] Fdn IRCCS Policlin San Matteo, Pediat Hematol Oncol, Pavia, Italy

[6] Univ Turin, Regina Margherita Childrens Hosp, Pediat Onco Hematol Stem Cell Transplantat & Cell, Turin, Italy

[7] Padua Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplant Div, Padua, Italy

[8] Univ Padua, Dept Womens & Childrens Hlth, Oncohematol Lab & Clin, Padua, Italy

[9] Univ Cattolica Sacro Cuore, Dept Pediat Hematol & Oncol, IRCCS Osped Pediatr Bambino Gesu, Rome, Italy

[10] Univ Cattolica Sacro Cuore, Bambino Gesu Childrens Hosp, Rome, Italy

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-189080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Toward a Measurable Residual Disease-Based Algorithm for Selection of Allogeneic Hematopoietic Stem Cell Transplant in Acute Myeloid Leukemia
Thuy Ho
Gor, Juhi
Bouligny, Ian
Murray, Graeme
Maher, Keri
BLOOD, 2023, 142
[22] Pre-transplant molecular minimal residual disease (MMRD) is associated with inferior outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Husnain, Muhammad
Komanduri, Krishna
Ramdial, Jeremy
Lekakis, Lazaros J.
Wang, Trent Peng
Goodman, Mark
Pereira, Denise L.
Beitinjaneh, Amer
Carollo, Douglas
Ali, Robert
Mohammed, Yaqub Nadeem
Arshad, Junaid
Byrnes, Diana
Saul, Eduardo Edelman
Aguirre, Luis E.
Jimenez, Antonio Martin
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23] Role of Measurable Residual Disease (MRD) Testing for the Prediction of Late Relapses Following Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia
Ali, Naveed
Megan, Othus
Rodriguez-Arboli, Eduardo
Orvain, Corentin
Milano, Filippo
Sandmaier, Brenda M.
Davis, Chris
Basom, Ryan S.
Appelbaum, Frederick R.
Walter, Roland B.
BLOOD, 2023, 142
[24] The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia
Czyz, Anna
Nagler, Arnon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
[25] Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia
Buccisano, Francesco
Maurillo, Luca
Piciocchi, Alfonso
Del Principe, Maria Ilaria
De Angelis, Gottardo
Di Veroli, Ambra
Cerretti, Raffaella
Cefalo, Mariagiovanna
Ditto, Concetta
Picardi, Alessandra
Cudillo, Laura
Mariotti, Benedetta
Lo Coco, Francesco
Arcese, William
Amadori, Sergio
Venditti, Adriano
BLOOD, 2015, 126 (23)
[26] MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Hao, Qi
Liu, Xinyue
Zhang, Yongping
Zhang, Dongmei
Li, Boran
Wang, Jingbo
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (10)
[27] Minimal Residual Disease (MRD) By Either Flow Cytometry or Cytogenetics Prior to an Allogeneic Hematopoietic Cell Transplant (allo-HCT) Predicts Poor Acute Myeloid Leukemia (AML) Outcomes
Katragadda, Lakshmikanth
Norkin, Maxim
Chang, Myron
Dai, Yunfeng
Moreb, Jan S.
May, W. Stratford
Coyle, Christopher R.
Leather, Helen
Li, Ying
Eldjerou, Lamis K.
Hiemenz, John W.
Brown, Randy A.
Wingard, John R.
BLOOD, 2015, 126 (23)
[28] The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT
Silva, Juliana
Galimard, Jacques-Emmanuel
Dalle, Jean-Hugues
Locatelli, Franco
Alsaedi, Hawazen S.
Angel Diaz, Miguel
Jubert, Charlotte
Bertrand, Yves
Simone, Giuseppina
Bader, Peter
Fagioli, Franca
Roussou, Vassiliki Kitra
Furness, Caroline
Wynn, Robert
Burkhardt, Birgit
Biffi, Alessandra
Bierings, Marc
de Heredia, Cristina Diaz
Prete, Arcangelo
Toren, Amos
Patrick, Katharine
Holter, Wolfgang
Dalissier, Arnaud
Rao, Kanchan
Corbacioglu, Selim
BLOOD, 2022, 140 : 12938 - 12940
[29] Pre-Transplant Exhausted Marrow Infiltrating T Lymphocytes in MRD Negative Patients with Acute Leukemia Predict Early Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation
Williams, Robin
Cooley, Sarah
Gordon, Peter M.
Bachanova, Veronika
Weisdorf, Daniel J.
Blazar, Bruce
Wagner, John E.
Miller, Jeffrey S.
Verneris, Michael R.
BLOOD, 2017, 130
[30] Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
Eduardo Rodríguez-Arbolí
Corentin Orvain
Megan Othus
Roland B. Walter
Bone Marrow Transplantation, 2022, 57 : 1732 - 1734

← 1 2 3 4 5 →